StonvexLoading…
StonvexStonvexStonvexCore line items from NOC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $9.88B | $41.95B | $30.24B | $19.82B |
Operating Income | $989.00M | $4.51B | $3.24B | $2.00B |
Net Income | $875.00M | $4.18B | $2.75B | $1.66B |
EPS (Diluted) | $6.14 | $29.08 | $19.12 | $11.45 |
Total Assets | $50.01B | $51.38B | $49.30B | $49.45B |
Total Liabilities | $32.89B | $34.70B | $33.31B | $33.98B |
Cash & Equivalents | $2.09B | $4.40B | $1.96B | $1.90B |
Free Cash Flow OCF − CapEx | $-1.82B | $3.31B | $72.00M | $-1.18B |
Shares Outstanding | 142.03M | 142.00M | 142.79M | 143.28M |